-+ 0.00%
-+ 0.00%
-+ 0.00%

Summit Therapeutics's US stock rose more than 10% in the premarket to $14.7.

Zhitongcaijing·08/26/2026 11:57:09
Listen to the news
Summit Therapeutics's US stock rose more than 10% in the premarket to $14.7.